Methylphenidate Extended-release Tablet, Orally Disintegrating
Product Images NDC 62542-350

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Methylphenidate Extended-release (NDC 62542-350). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Neos Therapeutics, Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Methylphenidate Extended Release Tablets 1)

Chemical structure of methylphenidate showing the molecular formula C14H19NO2 and molecular weight 233.31. The structure includes a piperidine ring, a phenyl group, and ester functional groups.*

FDA Label Image

Figure 2 (Methylphenidate Extended Release Tablets 2)

A line graph comparing mean d-methylphenidate plasma concentration (ng/mL) over time (hours) for Methylphenidate XR-ODT 2x25.9 mg tablets and Methylphenidate Extended Release Capsules 60 mg. The graph shows concentration levels rising, peaking around 4-6 hours, then gradually declining up to 36 hours.*

FDA Label Image

Figure 3 (Methylphenidate Extended Release Tablets 3)

A line graph depicting the mean SKAMP combined scores with standard error over time, comparing placebo and methylphenidate extended-release orally disintegrating tablet (XR-ODT). Scores are shown from pre-dose to 13 hours post-dose, with the methylphenidate XR-ODT group showing a marked decrease in scores initially, followed by a gradual increase, while the placebo group remains relatively stable.*

FDA Label Image

8.6 mg Tablet (Methylphenidate Extended Release Tablets 4)

Label for Methylphenidate Extended-Release Orally Disintegrating Tablets, 8.6 mg strength, by Neos Therapeutics, LP. The label states storage instructions, dosage form, and a warning not to crush or chew tablets. Contains 30 tablets. Includes a barcode and manufacturer contact information.*

FDA Label Image

17.3 mg (Methylphenidate Extended Release Tablets 5)

Label for Methylphenidate Extended-Release Orally Disintegrating Tablets from Neos Therapeutics, LP. The label specifies a strength of 17.3 mg per tablet and a package containing 30 tablets. The label includes storage instructions and a note not to crush or chew the tablets. The NDC is 62542-250-31.*

FDA Label Image

25.9 mg (Methylphenidate Extended Release Tablets 6)

Label for Methylphenidate Extended-Release Orally Disintegrating Tablets, 25.9 mg strength. The label indicates the product contains 30 tablets and includes storage instructions and a caution not to crush or chew the tablets. The labeler is Neos Therapeutics, LP, and it shows the NDC 62542-350-31 with Rx only status.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.